Search

everythinglearnresearchcommunity

for

Search:↓

The oral contraceptive with ethinyl estradiol and chlormadinone acetate is effective in treating moderate acne.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

The 2018 guideline for PCOS suggests new diagnostic criteria and treatments, but recognizes the need for more research.

A woman's male-pattern facial hair growth was caused by a rare malignant ovarian tumor that was difficult to diagnose and treat.

Women with high androgen levels may have more severe COVID-19 symptoms.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The document corrects an author's affiliation in previous articles about COVID-19 and its links to hair loss and hormones.

Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Anabolic steroid users may face higher risk of severe COVID-19.

Overweight women with PCOS are more likely to have excess male hormones.

A low-glycemic diet improved hormone levels and well-being in overweight women with high androgen levels.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Tributyltin exposure causes sex changes, sterilization, and decline in the snail Ocinebrina aciculata, risking its extinction.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.